Ixazomib, Gemcitabine, and Doxorubicin in Treating Participants With Locally Advanced or Metastatic Kidney Cancer

Conditions:   Kidney Medullary Carcinoma;   Stage III Renal Cell Cancer AJCC v8;   Stage IV Renal Cell Cancer AJCC v8
Interventions:   Drug: Doxorubicin;   Drug: Gemcitabine;   Drug: Ixazomib
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting

https://ift.tt/2LgLkMy